Baxter International Inc.

BAX · Healthcare

$24.35
+1.88% today

What a holder would want to know before buying BAX: where the price sits in its own history, how far it has fallen before and whether it recovered, and what the business behind it earns. All of it is arithmetic over free market data — no opinions, no recommendations.

Where the price sits
Low $15.80 · Mar 2026High $28.35 · Aug 2026

Today’s price is 54% above the lowest point of the past year and 14% below the highest.

Over the past year it was cheaper than today on 87% of days and more expensive on 13%. Over the last 10 years: cheaper on 10% of days.

16% above its average price of the last 200 trading days.

How bad does it get

Fell 20% or more 3 times in 10 years. The deepest fall was 83%; the longest took 6 months to get back to its peak. 2 of 3 have recovered so far.

It is in one now: 74% below the Apr 2020 peak.

Apr 2020
−83%not back yet
Feb 2020
−23%back in 2 months
Oct 2018
−21%back in 6 months
What you own

Baxter International Inc. · Healthcare · Medical Instruments & Supplies · a large company worth $12.59B

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems &…

Is it making money?
2022
2023
2024
2025

revenue profit

Sales of $11.24B in 2025, and a loss of $957.00M. Sales grew in 3 of the last 3 years.

Loses money on its sales at the moment.

Is it healthy?
Cash
$2.15B
Debt
$9.67B
Free cash flow / yr
$1.00B

Would need about 9.7 years of free cash flow to repay all its debt.

Is it expensive?

Not profitable over the last year. You pay $12 for every $1 of profit expected next year.

A high number means buyers expect growth; a low one means they expect little, or fear trouble. Large US companies have averaged roughly 15–20 over the decades.

Pays 0.17% a year in dividends at today’s price · next ex-dividend Aug 28.

What others are doing

14 analysts: 2 say buy, 11 hold, 1 sell. Their average 12-month target is $27.92 (range $20.00–$40.00).

Insiders made 0 purchases and 0 sales in the last 6 months.

Free data from Yahoo Finance, refreshed daily. This is evidence about the business and its price history, not a recommendation.

Now try it without risking anything

Poshkan is paper trading: real prices, virtual money. Buy BAX with $10,000 that isn’t real, set a stop before you enter, and find out what your idea would actually have done.

Data from Yahoo Finance, refreshed hourly. Nothing here is financial advice. Poshkan is a paper-trading simulator — all money, trades and returns are virtual.